Model
Edge
Revance Therapeutics Inc.
0001678984
Filing Type
4
Filing Date
3/18/2024
Updated
3/19/24, 12:44 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership